| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/07/2011 | CA2349838C Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| 06/07/2011 | CA2306216C The use of inhibitors of the renin-angiotensin system for the treatment of cachexia and wasting |
| 06/07/2011 | CA2213759C Method for treating amyloidosis |
| 06/03/2011 | WO2011065552A1 Nutritional composition beneficial to small intestine |
| 06/03/2011 | WO2011065545A1 5-FLUOROURACIL COMPOUND HAVING dUTPase-INHIBITING ACTIVITY OR SALT THEREOF |
| 06/03/2011 | WO2011065541A1 Anti-tumor effect potentiator |
| 06/03/2011 | WO2011065519A1 Substituted oxopiperazine compound |
| 06/03/2011 | WO2011065480A1 Nerve cell death inhibitor |
| 06/03/2011 | WO2011065420A1 Method for manufacturing a 6-substituted-1-methyl-1h-benzimidazole derivative, and manufacturing intermediate from said method |
| 06/03/2011 | WO2011065402A1 Indole compound and pharmaceutical use thereof |
| 06/03/2011 | WO2011065389A1 Method for screening of therapeutic agent for hyperlipemia |
| 06/03/2011 | WO2011065335A1 Preventing or ameliorating agent for hypersensitivity in sensitive skin |
| 06/03/2011 | WO2011065300A1 Antiviral agent and food/beverage composition |
| 06/03/2011 | CA2782280A1 Anti-tumor effect potentiator |
| 06/03/2011 | CA2781800A1 Method for manufacturing a 6-substituted 1-methyl-1h-benzimidazole derivative and an intermediate of said method |
| 06/03/2011 | CA2781660A1 Indole compound and pharmaceutical use thereof |
| 06/02/2011 | US20110130449 Assay for Monitoring Activity of Jmjd6 |
| 06/02/2011 | US20110130444 Methods and compositions for targeted delivery of gene therapeutic vectors |
| 06/02/2011 | US20110130399 Phthalazine Derivatives with Angiogenesis Inhibiting Activity |
| 06/02/2011 | US20110130373 Methods for administration and formulations for the treatment of regional adipose tissue |
| 06/02/2011 | US20110130364 Pyrrolopyridine derivatives substituted with cyclic amino group |
| 06/02/2011 | US20110130353 Highly purified antiendotoxin compound |
| 06/02/2011 | US20110129896 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3Beta PROTEIN AND PROTEIN COMPLEXES |
| 06/02/2011 | US20110129555 Burglarproof spraying liquid |
| 06/02/2011 | US20110129554 Method For Preparation Of Eucalyptus Extract |
| 06/02/2011 | US20110129436 Polyglycerol sebecate peritoneal adhesion prevention barrier |
| 06/02/2011 | US20110129425 Process for preparing a pharmaceutical formulation of contrast agents |
| 06/02/2011 | US20110129423 Anticancer compounds and screening method |
| 06/02/2011 | US20110129420 Materials and methods for biological imaging |
| 06/02/2011 | US20110129418 Brain Tumor Targeting Peptides and Methods |
| 06/02/2011 | US20110126767 Methods and compositions for increasing the hatchability of hatchery eggs |
| 06/01/2011 | EP2327789A1 Novel compound signamycin, method for production thereof, and use thereof |
| 06/01/2011 | EP2327775A2 Therapy for alpha-galactosidase a deficiency |
| 06/01/2011 | EP2327705A1 Podophyllotoxins as antiproliferative agents |
| 06/01/2011 | EP2327690A1 Tricyclic compound |
| 06/01/2011 | EP2327451A2 Method for detecting and inhibiting angiogenesis |
| 06/01/2011 | EP2327422A1 Activin antagonists for diagnosis and therapy of diseases associated with fibrosis |
| 06/01/2011 | EP2327408A1 Tetracyclic cyclic gmp-specific phosphodiesterase inhibitors for the treatment of benign prostatic hypertrophy |
| 06/01/2011 | EP2326643A2 Benzoquinoline inhibitors of vesicular monoamine transporter 2 |
| 06/01/2011 | EP2326321A1 Taurine or taurine-like substances for the prevention of brain oedema |
| 06/01/2011 | EP2326315A1 Treatment of an autoimmune disease using il-18 antagonists |
| 06/01/2011 | EP1379510B1 Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chemosensitizers |
| 06/01/2011 | EP1073759B1 Recombinant virus expressing foreign dna encoding feline cd80, feline cd28, feline ctla-4 or feline cd86 and uses thereof |
| 06/01/2011 | CN1934103B Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
| 06/01/2011 | CN1893837B Serum remnant-like lipoprotein concentration regulator |
| 06/01/2011 | CN102083810A Activator for peroxisome proliferator-activated receptor |
| 06/01/2011 | CN102083449A Xanthine oxidase inhibitor and uric acid production inhibitor |
| 06/01/2011 | CN102079790A Recombination fusion protein PACAP-PTD (Pituitary Adenylate Cyclase Activating Peptide-Protein Transduction Domain) as well as expression method and application thereof |
| 06/01/2011 | CN102079746A Pyrazolo-quinazoline derivatives,process for their preparation and their use as kinase inhibitors |
| 06/01/2011 | CN102079743A Dipeptidyl peptidase inhibitors |
| 06/01/2011 | CN102078613A Inhibitors of her3 activity |
| 06/01/2011 | CN102078608A Formulation of human antibodies for treating tnf-alpha associated disorders |
| 06/01/2011 | CN102078497A Compound anti-pecking powder with traditional Chinese medicine prescription and application method thereof |
| 06/01/2011 | CN102078493A Preparation method and application of compound astragalus root preparation |
| 06/01/2011 | CN102078367A Use of aidi preparation in preparation of medicaments for treating multiple organ dysfunction syndrome in elderly |
| 06/01/2011 | CN102078336A Traditional Chinese medicine composition with function of improving microcirculation and preparation method and application thereof |
| 06/01/2011 | CN101810787B Chinese medicinal composition for treating dysphoria and preparation method thereof |
| 06/01/2011 | CN101607016B External medicine for treating swelling from blood stases |
| 06/01/2011 | CN101396457B Traditional Chinese medicine composition for treating stomach intestine adynamia of multi viscera organs incompetence syndrome |
| 06/01/2011 | CN101099860B Use of erythropoietin |
| 05/31/2011 | US7951972 Human adam-10 inhibitors |
| 05/31/2011 | US7951931 Nucleic acid encoding sodium channel SCN3A alpha subunits |
| 05/31/2011 | US7951840 Zinc salt compositions for the prevention of dermal and mucosal irritation |
| 05/31/2011 | US7951830 Compounds effecting glucokinase |
| 05/31/2011 | US7951821 N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy |
| 05/31/2011 | US7951820 Triazole compounds useful as protein kinase inhibitors |
| 05/31/2011 | US7951793 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 05/31/2011 | US7951546 Compositions and methods for the diagnosis and treatment of tumor |
| 05/31/2011 | US7951402 Drug delivery particle |
| 05/31/2011 | US7951397 Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient |
| 05/31/2011 | US7951378 Modified cell adhesion molecule comprising immunoglobulin heavy chain fusion for treatment and prevention of respiratory system disorders |
| 05/31/2011 | CA2634299C Process for preparing inhibitors of nucleoside metabolism |
| 05/31/2011 | CA2480470C Inhibitors of nucleoside phosphorylases and nucleosidases |
| 05/31/2011 | CA2475764C New inhibitors of histone deacetylase |
| 05/31/2011 | CA2466135C Use of propionyl l-carnitine or one of its pharmacologically acceptable salts for the preparation of a medicine for the treatment of la peyronie's disease |
| 05/31/2011 | CA2455635C Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 05/31/2011 | CA2451626C One dose vaccination with mycoplasma hyopneumoniae |
| 05/31/2011 | CA2443488C Mercaptoacetylamide derivatives, a process for their preparation and their use |
| 05/31/2011 | CA2430692C Geldanamycin derivative and use of same to treat cancer |
| 05/31/2011 | CA2412501C Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury |
| 05/31/2011 | CA2400929C Antagonistic selective binding agents of osteoprotegerin binding protein |
| 05/31/2011 | CA2398929C Neuroprotective, antithrombotic and anti-flammatory uses of activated protein c (apc) |
| 05/31/2011 | CA2398539C Myeloid colony stimulating factor and uses thereof |
| 05/31/2011 | CA2369725C Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines |
| 05/31/2011 | CA2319080C Multivalent antibacterial agents |
| 05/31/2011 | CA2231772C Advanced glycation end-product intermediaries and post-amadori inhibition |
| 05/26/2011 | WO2011063102A1 Apremilast for the treatment of sarcoidosis |
| 05/26/2011 | WO2011062298A1 System for increasing gene expression, and vector supporting said system |
| 05/26/2011 | WO2011062253A1 Novel fused pyrimidine derivative |
| 05/26/2011 | WO2011062194A1 Aminopyridine derivative |
| 05/26/2011 | WO2011062147A1 Method for inducing differentiation of dental pulp cells into odontoblasts |
| 05/26/2011 | WO2011062013A1 Inducer of selective differentiation into neural stem cells and/or neural precursor cells |
| 05/26/2011 | WO2011061932A1 Ceramide and collagen synthesis promoter and collagen saccharification inhibitor |
| 05/26/2011 | WO2011061736A1 Alkaline alpha galactosidase for the treatment of fabry disease |
| 05/26/2011 | WO2011061667A1 Use of macrocyclic lactone derivatives for the treatment of inflammatory disorders |
| 05/26/2011 | WO2011060585A1 Chewable tablets including essences of five-colour fruits and vegetables and preparative methods thereof |
| 05/26/2011 | WO2011009042A3 Antigen compositions and methods of inhibiting campylobacter jejuni bacterial infection and uses of the antigen compositions |
| 05/26/2011 | US20110126302 Diagnostic and therapeutic methods for efmr (epilepsy and mental retardation limited to females) |
| 05/26/2011 | US20110124887 Epigallocatechin dimers or trimers having lipase inhibitory activity and/or antioxidant activity |
| 05/26/2011 | US20110124872 Derivatives of pryidone and use thereof |